InvestorsHub Logo
Followers 4
Posts 1139
Boards Moderated 0
Alias Born 04/27/2006

Re: maumar post# 5005

Tuesday, 12/06/2016 6:46:14 PM

Tuesday, December 06, 2016 6:46:14 PM

Post# of 8553
"The results show that Datarumumab might lead to reduction of infusion time by around 30 minutes."

According to Genmab presentation, IV 3-7 hours, SC 30 minutes.
"The median duration of first, second, and subsequent IV infusions was
7.0, 4.2, and 3.4 hours, respectively4"

Genmab confirmed large Phase III DARA-SC starting 2017 with data expected 2019.

ASH 2016 Data Review Meeting

http://www.genmab.com/


Never argue with a fool, for after awhile, it becomes difficult to determine which is the fool.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent HALO News